Deroy & Devereaux Private Investment Counsel’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Deroy & Devereaux Private Investment Counsel's BIIB Position: Q4 2020 in Review
Deroy & Devereaux Private Investment Counsel sold out of Biogen (BIIB) in Q4 2020, closing a stake of 875 shares — an estimated $248K sold.
Deroy & Devereaux Private Investment Counsel first reported a position in BIIB in Q2 2013 and held it in 30 quarters. The position peaked at $422K in Q1 2015. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.
- Deroy & Devereaux Private Investment Counsel reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
- Deroy & Devereaux Private Investment Counsel sold 875 Biogen shares in Q4 2020, an estimated $248K.
- Deroy & Devereaux Private Investment Counsel first reported a position in Biogen in Q2 2013 and held it in 30 quarters.
- Deroy & Devereaux Private Investment Counsel's Biogen position peaked at $422K in Q1 2015.
- 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.
Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q4 2020, filed 25 Jan 2021.